TrialDrug design, development and therapy2025

Pharmacokinetic and Safety Profiles of MIT-001, a Novel Ferroptosis Inhibitor, After Subcutaneous Administration in Healthy Participants.

Sujong Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.